Security key
640979100
Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)
CUSIP: 640979100
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 65,233,736
- Total 13F value
- $65,235,367
- Share change
- -15,269,200
- Put/Call ratio
- 58%
- SEC-reported price per share
- $1.00
- Number of holders
- 111
- Value change
- -$163,396,114
- Number of buys
- 59
- Number of sells
- 79
- Shares outstanding
- 186,788,806
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
111
Top holders
10
NMRA full security history
Ownership snapshot
Full 13F holder table
Neumora Therapeutics, Inc. SEC filings
Neumora Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Paul L. Berns
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
3/4/5
Lead comparable stake: 5.1%
13D/G row: Paul L. Berns
Showing 1-6 of 15 holder rows.
Quick read
Paul L. Berns leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Paul L. Berns's linked filing trail.
Comparable ownership
Top 5
Paul L. Berns
5.1%
FMR LLC
2.2%
BlackRock, Inc.
3.8%
SOFTBANK GROUP CORP.
3.5%
T. Rowe Price Investment Manageme...
2.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Paul L. Berns |
13D/G
|
5.1%
|
$6,334,229
8,226,272 shares
|
$0 | 31 Dec 2024 |
| FMR LLC |
13F
13D/G
3/4/5
Company · Other*
|
2.2%
from 13D/G
|
$83,088,916
7,838,577 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
3.8%
|
$75,334,159
7,106,996 shares
|
— | 31 Dec 2024 |
| SOFTBANK GROUP CORP. |
13F
Company
|
3.5%
|
$69,336,614
6,541,190 shares
|
— | 31 Dec 2024 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
2.7%
|
$53,030,000
5,002,799 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.4%
|
$48,466,465
4,572,308 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
111
Shares
65,233,736
Rows available
111
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
111
Q1 2025 holders
111
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|